Skip to Content
Menu

SIGMOLECS®

Technology is the New Era of Medicine

SIGMOLECS® Technology is an advanced chemical profiling through structural assembling of key molecules, mostly proteins and peptides, that form actuated molecules by specifically:

  • Improving their bio-activity in solution and in vivo;
  • Increasing their transmembrane penetration;
  • Creating precise specificity of action, particularly in intracellular signaling.

The result is like a program code of the cells, deploying them to organize into specific patterns. SIGMOLECS® talks to the cells in their language.

Question: “SIGMOLECS® technology is based on what you call adaptive medicine, can you explain?”

Listen to Dr JO’s answer 

SIGMOLECS® Technology was conceived and engineered by Dr JO Serrentino exclusively for Contrad Swiss.